About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Kidney Disease Clinical Trials in Chicago | 135 Studies

Clinical Trials Kidney DiseaseChicago

Kidney Disease Clinical Trials in Chicago

Find 135 clinical trials for kidney disease near Chicago, Illinois. Connect with research centers in your area.

All Kidney Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 135 trials

CompletedA Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy PatientsThis study is being conducted to evaluate the safety and efficacy of treatment with CTP-499 for 24 weeks in patients with chronic kidney disease, Type 2 diabetic nephropathy and…NCT01487109·Tempe, Arizona and 48 others

Kidney Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of the Safety and Tolerance of Regadenoson in Subjects With Renal ImpairmentThis study is intended to assess the safety and tolerance of regadenoson in subjects with renal impairment.NCT00863707·Anniston, Alabama and 40 others

RecruitingA Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseThe purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease.NCT06830629·Decatur, Alabama and 78 others

CompletedAnemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)The purpose of this multi-center study is to evaluate the efficacy and safety of daprodustat in subjects with anemia associated with CKD.NCT03029208·Anaheim, California and 110 others

CompletedPROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD PatientsThe purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in…NCT00440466·Chula Vista, California and 65 others

CompletedA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseThis study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse.NCT06926660·Huntsville, Alabama and 156 others

CompletedA Study of Intravenous Mircera for the Treatment of Anemia in Dialysis PatientsThis study will assess the efficacy and safety of intravenous Mircera, given as maintenance treatment for renal anemia in chronic kidney disease patients on dialysis who were…NCT00077610·Birmingham, Alabama and 98 others

CompletedA Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 DiabetesResearchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys' ability to work properly, and type 1 diabetes.NCT05901831·Surprise, Arizona and 79 others

TerminatedA Phase 1, Open-label Safety Study of NKA in Patients With Type 2 DiabetesThe purpose of this study is to determine if selected renal cells, obtained by biopsy from a patient with chronic kidney disease (CKD) and Type 2 Diabetes (i.e., autologous cells)…NCT02008851·Chicago, Illinois and 4 others

RecruitingTargeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, EmpagliflozinSickle cell anemia (SCA) is an inherited red blood disorder. The kidneys are among the most commonly affected organ systems in SCA.NCT07175051·Chicago, Illinois

CompletedMultiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)An open-label, Phase II, multi-center study evaluating multiple doses of DM199 in participants with chronic kidney disease.NCT04123613·Mesa, Arizona and 13 others

CompletedSleep Disturbances as a Risk Factor in Chronic Kidney DiseaseThis study is designed to determine if either short night time sleep or poor night time sleep could be a risk factor for increasing the rate at which kidney function deteriorates…NCT00817427·Chicago, Illinois

TerminatedAn Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with chronic kidney disease (CKD) who previously…NCT03749447·Birmingham, Alabama and 86 others

TerminatedA Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of HyperkalaemiaThe purpose of this study is to evaluate the effect of Sodium Zirconium Cyclosilicate (SZC), as adjunct to ACEi/ARB therapy (lisinopril or valsartan), on slowing CKD progression…NCT05056727·Surprise, Arizona and 275 others

Active not recruitingEffect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney DiseaseThe goal of this study is to better understand the effects of a sodium-glucose transport protein 2 inhibitor, dapagliflozin, added on to standard of care on heart and lung…NCT05719714·Chicago, Illinois

CompletedA Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesThe main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or…NCT05936151·Chandler, Arizona and 41 others

CompletedContinuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis PatientsThe purpose of this study is to confirm the safety and efficacy of Soluble Ferric Pyrophosphate (SFP) dialysate solution in maintaining iron delivery for erythropoiesis in anemic…NCT01320202·Bakersfield, California and 46 others

TerminatedEvaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on HemodialysisTo evaluate the survival benefit associated with Zemplar therapy as compared to Calcijex for the treatment of secondary hyperparathyroidism in subjects with Stage V chronic kidney…NCT00062699·Tuscaloosa, Alabama and 59 others

CompletedPharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised SubjectsThe goal of this clinical trial was to compare transdermal glomerular filtration rate (tGFR) to plasma-derived indexed (to body surface area; BSA) GFR (nGFR) using MB-102…NCT05425719·Edgewater, Florida and 7 others

TerminatedStudy to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney DiseaseThe primary objectives of this study are the following: 1.NCT00436748·Birmingham, Alabama and 66 others

PreviousPage 5 of 7Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia